Pancreatic Cancer Research

ResearcherMedical University of LodzActive in the last 2 years

Janusz Strzelczyk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3438-9512; OpenAlex author ID A5039986027. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 17

  1. Coagulation disorders and thromboprophylaxis in pancreatic cancer: a review of current evidence and clinical challenges. Co-author DOI 10.1007/s11239-026-03253-z↗
  2. The effect of gastrojejunostomy on carbohydrate metabolism in patients with pancreatic cancer. Last author DOI 10.5114/pg.2026.160484↗
  3. Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment. Co-author DOI 10.3390/biomedicines12112596↗
  4. Hedgehog Signaling Pathway Proteins in Prognosis of Pancreatic Ductal Adenocarcinoma and Its Differentiation From Chronic Pancreatitis. Co-author DOI 10.1097/mpa.0000000000002001↗
  5. FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Co-author DOI 10.3390/biomedicines11010077↗
  6. Comparison of clinical usefulness of serum Ca125 and CA19-9 in pancreatic adenocarcinoma diagnosis: meta-analysis and systematic review of literature. Co-author DOI 10.1080/1354750x.2021.1876770↗
  7. Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis. Co-author DOI 10.3390/jcm10245804↗
  8. Thyroid hormones concentration in portal and peripheral blood in patients with pancreatic cancer: Preliminary study. Co-author DOI 10.3233/cbm-201595↗
  9. Elevated preoperative levels of CA 19-9 and CA 125 predicts overall survival time in the pancreatic adenocarcinoma. Single institution series. Last author DOI 10.5604/01.3001.0014.0950↗
  10. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Co-author DOI 10.5114/pg.2019.83422↗
  11. Metastatic Pancreatic Cancer. Last author DOI 10.1080/08941939.2017.1291774↗
  12. Concentration of D-dimers in Bile-a Novel Marker of Pancreatic Cancer Enhancing Accuracy of Standard CA19-9 Measurement: Dual Test Hypothesis. Last author DOI 10.1097/mpa.0000000000000696↗
  13. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. Co-author DOI 10.1155/2017/3276806↗
  14. The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer. Last author DOI 10.1186/s12957-017-1291-4↗
  15. Portal blood - a new source of dendritic cells for pancreatic cancer vaccine. Last author DOI 10.1016/j.pan.2014.07.009↗
  16. D-dimers revisited: a new marker of pancreatic cancer. Last author DOI 10.1097/coc.0000000000000060↗
  17. Very high concentration of D-dimers in portal blood in patients with pancreatic cancer. Last author DOI 10.2478/v10035-012-0087-z↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Piotr Hogendorf · 13 shared papers, 2012–2026 · strength 1.93
  2. Adam Durczyński · 13 shared papers, 2012–2026 · strength 1.91
  3. Alicja Majos · 4 shared papers, 2020–2026 · strength 0.86
  4. Oliwia Grząsiak · 3 shared papers, 2022–2026 · strength 0.73
  5. Wojciech Ciesielski · 3 shared papers, 2022–2026 · strength 0.71
  6. Aleksander Skulimowski · 5 shared papers, 2017–2021 · strength 0.57
  7. Katarzyna Winter · 3 shared papers, 2019–2022 · strength 0.41
  8. Agata Grochowska · 1 shared paper, 2026 · strength 0.33
  9. Ewa I. Malecka-Panas · 3 shared papers, 2017–2021 · strength 0.31
  10. Ewa Małecka-Wojciesko · 1 shared paper, 2022 · strength 0.17
  11. Stanisław Głuszek · 1 shared paper, 2019 · strength 0.08
  12. Anita Gąsiorowska · 1 shared paper, 2019 · strength 0.08
  13. Marek Durlik · 1 shared paper, 2019 · strength 0.08
  14. Renata Talar‐Wojnarowska · 1 shared paper, 2019 · strength 0.08
  15. Paweł Lampe · 1 shared paper, 2019 · strength 0.08
  16. A Dâbrowski · 1 shared paper, 2019 · strength 0.08
  17. Łukasz Durko · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.